PGS Sample Set (PSS): PSS009509

Phenotype eGFR<60 mL/min/1.73m2 used to define CKD (stage 3 or greater)
Sample Ancestry Hispanic or Latin American

Sample Numbers

Total number
4,264 individuals
Detailed numbers
1,386 cases (32.5%)
2,878 controls
0.51% Male samples
Age of Study Participants Mean : 64.0 years
Number of Cohort(s) 3
Sample distribution
Sample gender distribution

Cohort(s)

Cohort Short Name Cohort Full Name Previous/other/additional names (e.g. sub-cohorts)
BioMe BioMe® BioBank Program (Institute for Personalized Medicine at the Icahn School of Medicine at Mount Sinai) BioMe Biobank (BMBB), MT. SINAI BioMe Biobank Platform (IMP), Charles R Bronfman Institute for Personalized Medicine - IPM / BioBank Genome Wide Association Study of Cardiovascular, Renal and Metabolic Phenotypes (IPM), Charles R Bronfman Institute for Personalized Medicine - IPM / BioBank Genome Wide Association Study of Cardiovascular, Renal and Metabolic Phenotypes I (IPM I), Charles R Bronfman Institute for Personalized Medicine - IPM / BioBank Genome Wide Association Study of Cardiovascular, Renal and Metabolic Phenotypes II (IPM II), IPM_EA_Affy, IPM_EA_Illu, Mount Sinai BioMe BioBank (Mount Sinai)
eMERGE Medical Records and Genomics study
UKB UK Biobank